These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 8506916

  • 1. Nucleolar organizer regions in determining malignancy of pigmented conjunctival lesions.
    Saornil MA, Marcus DM, Doepner D, Apolone G, Torre V, Albert DM.
    Am J Ophthalmol; 1993 Jun 15; 115(6):800-5. PubMed ID: 8506916
    [Abstract] [Full Text] [Related]

  • 2. Nucleolar organizer regions in iris nevi and melanomas.
    Marcus DM, Mawn LA, Egan KM, Albert DM.
    Am J Ophthalmol; 1992 Aug 15; 114(2):202-7. PubMed ID: 1642296
    [Abstract] [Full Text] [Related]

  • 3. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
    González-Cámpora R, Armas-Padrón JR, Rios-Martín JJ, López-Garrido J, Gómez-Pascual A, Galera-Davidson H.
    Anal Quant Cytol Histol; 1991 Feb 15; 13(1):16-22. PubMed ID: 1709022
    [Abstract] [Full Text] [Related]

  • 4. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
    Di Gregorio C, Losi L, Annessi G, Botticelli A.
    Am J Dermatopathol; 1991 Aug 15; 13(4):329-33. PubMed ID: 1928617
    [Abstract] [Full Text] [Related]

  • 5. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
    LeBlanc RE, Miller DM, Zegans ME.
    J Cutan Pathol; 2021 Dec 15; 48(12):1442-1448. PubMed ID: 34089198
    [Abstract] [Full Text] [Related]

  • 6. Silver staining of nucleolar organizer regions in malignant melanoma and melanotic nevi.
    Leong AS, Gilham P.
    Hum Pathol; 1989 Mar 15; 20(3):257-62. PubMed ID: 2470664
    [Abstract] [Full Text] [Related]

  • 7. Nucleolar organizer regions in conjunctival nevi and melanomata.
    Koren R, Rath-Wolfson L, Appel I, Pe'er J, Paz A, Klein T, Klein B, Mishaeli M, Gal R.
    Oncol Rep; 1998 Mar 15; 5(5):1079-81. PubMed ID: 9683812
    [Abstract] [Full Text] [Related]

  • 8. The value of nucleolar organizer regions in uveal melanoma. The Collaborative Ocular Melanoma Study Group.
    Marcus DM, Minkovitz JB, Wardwell SD, Albert DM.
    Am J Ophthalmol; 1990 Nov 15; 110(5):527-34. PubMed ID: 1700611
    [Abstract] [Full Text] [Related]

  • 9. Management of pigmented conjunctival lesions.
    Oellers P, Karp CL.
    Ocul Surf; 2012 Oct 15; 10(4):251-63. PubMed ID: 23084146
    [Abstract] [Full Text] [Related]

  • 10. In vivo confocal microscopy of pigmented conjunctival tumors.
    Messmer EM, Mackert MJ, Zapp DM, Kampik A.
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov 15; 244(11):1437-45. PubMed ID: 16598465
    [Abstract] [Full Text] [Related]

  • 11. Pigmented conjunctival and scleral lesions.
    Liesegang TJ.
    Mayo Clin Proc; 1994 Feb 15; 69(2):151-61. PubMed ID: 8309267
    [Abstract] [Full Text] [Related]

  • 12. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
    Nagatani T, Iemoto G, Miyakawa K, Ichiyama S, Takahashi Y, Uchiyama M, Nakajima H.
    J Dermatol; 1991 Dec 15; 18(12):731-5. PubMed ID: 1806604
    [Abstract] [Full Text] [Related]

  • 13. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
    Naik R, Raghuveer CV, Jacob DL.
    J Indian Med Assoc; 1997 Jul 15; 95(7):420-1. PubMed ID: 9425842
    [Abstract] [Full Text] [Related]

  • 14. Nucleolar organizer regions in Spitz nevi and malignant melanomas.
    Howat AJ, Giri DD, Cotton DW, Slater DN.
    Cancer; 1989 Feb 01; 63(3):474-8. PubMed ID: 2912525
    [Abstract] [Full Text] [Related]

  • 15. Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens.
    Novais GA, Fernandes BF, Belfort RN, Castiglione E, Cheema DP, Burnier MN.
    Int J Surg Pathol; 2010 Feb 01; 18(1):60-3. PubMed ID: 18611943
    [Abstract] [Full Text] [Related]

  • 16. Prognosing melanomas: the argyrophilic nucleolar organizer region approach.
    Rebora A.
    Dermatology; 1992 Feb 01; 185(3):166-8. PubMed ID: 1446080
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.
    Soon AK, Brownstein S, Tang T, Saleh S, Jiang K, Levac J, Blanco P, Farmer J.
    Can J Ophthalmol; 2019 Dec 01; 54(6):699-707. PubMed ID: 31836103
    [Abstract] [Full Text] [Related]

  • 18. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A, Söylemez F, Ensari A.
    Am J Obstet Gynecol; 2001 Mar 01; 184(4):567-74. PubMed ID: 11262454
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of nucleolar organizer regions (NORS) in malignant melanoma.
    Ronan SG, Farolan MJ, McDonald A, Manaligod JR, Das Gupta TK.
    J Cutan Pathol; 1994 Dec 01; 21(6):494-9. PubMed ID: 7699115
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE, Ober K, Dubbink HJ, Paridaens D, Naus NC, Belunek S, Krist B, Post E, Zwarthoff EC, de Klein A, Verdijk RM, Rotterdam Ocular Melanoma Study Group.
    Invest Ophthalmol Vis Sci; 2014 Aug 26; 55(9):6024-30. PubMed ID: 25159205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.